Free Trial

Iradimed (IRMD) News Today

$42.31
-0.73 (-1.70%)
(As of 06/18/2024 ET)
Iradimed logo with Medical background
Iradimed Corporation (NASDAQ:IRMD) Stock Holdings Raised by RK Capital Management LLC
RK Capital Management LLC boosted its stake in Iradimed Corporation (NASDAQ:IRMD - Free Report) by 13.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 340,400 shares of the medical equipme
Iradimed logo with Medical background
Short Interest in Iradimed Corporation (NASDAQ:IRMD) Decreases By 6.2%
Iradimed Corporation (NASDAQ:IRMD - Get Free Report) was the recipient of a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 97,600 shares, a decrease of 6.2% from the April 30th total of 104,000 shares. Based on an average daily trading volume, of 49,600 shares, the short-interest ratio is presently 2.0 days. Approximately 1.2% of the company's stock are short sold.
Iradimed Corporation (NASDAQ:IRMD) Declares Quarterly Dividend of $0.15
Iradimed Corporation (NASDAQ:IRMD) declared a quarterly dividend on Thursday, May 2nd. Shareholders of record on Monday, May 20th will be given a dividend of 0.15 per share by the medical equipment provider on Thursday, May 30th. This represents a $0.60 annualized dividend and a yield of 1.34%. The ex-dividend date is Friday, May 17th.
Iradimed (NASDAQ:IRMD) Issues Q2 2024 Earnings Guidance
Iradimed (NASDAQ:IRMD) updated its second quarter 2024 earnings guidance. The company provided EPS guidance of 0.360-0.390 for the period, compared to the consensus estimate of 0.370. The company also issued revenue guidance of $17.6 millionillion-$17.8 millionillion, compared to the consensus estimate of $17.9 millionillion.
iRadimed Q1 2024 Earnings Preview
Iradimed (IRMD) Scheduled to Post Quarterly Earnings on Thursday
Iradimed (NASDAQ:IRMD) will be releasing earnings before the market opens on Thursday, May 2, Zacks reports.
Equities Analysts Offer Predictions for Iradimed Corporation's Q1 2024 Earnings (NASDAQ:IRMD)
Iradimed Corporation (NASDAQ:IRMD - Free Report) - Research analysts at Roth Capital issued their Q1 2024 earnings estimates for shares of Iradimed in a note issued to investors on Monday, April 22nd. Roth Capital analyst J. Wittes expects that the medical equipment provider will earn $0.31 per s
Iradimed (NASDAQ:IRMD) Receives Buy Rating from Roth Capital
Roth Capital reaffirmed a "buy" rating on shares of Iradimed in a report on Monday.
Iradimed (NASDAQ:IRMD) Rating Reiterated by Roth Mkm
Roth Mkm reissued a "buy" rating and set a $65.00 price target on shares of Iradimed in a research note on Monday.
Iradimed's (IRMD) "Buy" Rating Reaffirmed at Singular Research
Singular Research reissued a "buy" rating on shares of Iradimed in a research report on Monday.
Iradimed Corporation (NASDAQ:IRMD) Sees Significant Increase in Short Interest
Iradimed Corporation (NASDAQ:IRMD - Get Free Report) was the recipient of a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 112,900 shares, an increase of 11.0% from the February 29th total of 101,700 shares. Based on an average daily volume of 54,200 shares, the short-interest ratio is presently 2.1 days. Approximately 1.4% of the shares of the stock are short sold.
Resource Consulting Group Inc. Purchases New Stake in IRadimed Co. (NASDAQ:IRMD)
Resource Consulting Group Inc. acquired a new position in IRadimed Co. (NASDAQ:IRMD - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 103,000 shares of the medical equipment provider's stock,
IRadimed Co. (NASDAQ:IRMD) Sees Significant Growth in Short Interest
IRadimed Co. (NASDAQ:IRMD - Get Free Report) was the target of a large increase in short interest in the month of February. As of February 29th, there was short interest totalling 101,700 shares, an increase of 5.7% from the February 14th total of 96,200 shares. Currently, 1.3% of the company's shares are sold short. Based on an average daily volume of 52,200 shares, the days-to-cover ratio is presently 1.9 days.
IRMD Jul 2024 60.000 call
iRadimed Corp.
SG Capital Management LLC Buys New Shares in IRadimed Co. (NASDAQ:IRMD)
SG Capital Management LLC acquired a new stake in shares of IRadimed Co. (NASDAQ:IRMD - Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 12,358 shares of the medical equipment provider's stock, valued at approx
EAM Investors LLC Sells 21,092 Shares of IRadimed Co. (NASDAQ:IRMD)
EAM Investors LLC reduced its stake in shares of IRadimed Co. (NASDAQ:IRMD - Free Report) by 50.7% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,476 shares of the medical equipment
IRadimed (NASDAQ:IRMD) Shares Gap Down to $46.76
IRadimed (NASDAQ:IRMD) Shares Gap Down to $46.76
Should You Invest in IRadimed Corporation (IRMD)?
IRMD Mar 2024 40.000 call
IRMD Mar 2024 45.000 put
IRMD Feb 2024 44.520 call
IRadimed (NASDAQ:IRMD) Updates Q1 2024 Earnings Guidance
IRadimed (NASDAQ:IRMD) updated its first quarter 2024 earnings guidance. The company provided EPS guidance of 0.330-0.350 for the period, compared to the consensus estimate of 0.410. The company also issued revenue guidance of $17.0 millionillion-$17.3 millionillion, compared to the consensus estimate of $17.6 millionillion.
IRadimed: Q4 Earnings Snapshot
iRadimed's Earnings Outlook
iRadimed Q4 2023 Earnings Preview
Lake Street Reaffirms Their Buy Rating on Iradimed (IRMD)
Get Iradimed News Delivered to You Automatically

Sign up to receive the latest news and ratings for IRMD and its competitors with MarketBeat's FREE daily newsletter.

The ONE AI Stock to own now. (It’s not Nvidia.) (Ad)

Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …

Click here to see the presentation now.

IRMD Media Mentions By Week

IRMD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IRMD
News Sentiment

1.89

0.91

Average
Medical
News Sentiment

IRMD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IRMD Articles
This Week

1

2

IRMD Articles
Average Week

Get Iradimed News Delivered to You Automatically

Sign up to receive the latest news and ratings for IRMD and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:IRMD) was last updated on 6/18/2024 by MarketBeat.com Staff

From Our Partners